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each patient was blinded as to which shunt was next to be assigned.
Analysis of effectiveness
The analysis of the clinical study was based on intention to treat. The primary outcomes used in the analysis were: variceal rehaemorrhage, shunt occlusion, shunt revision, shunt failure, early mortality, and readmission rate. Patients undergoing TIPS and HGPCS were demographically similar, and similar in degree of cirrhosis, cause of cirrhosis and type of varices.
Effectiveness results
After TIPS six patients were admitted a total of seven times for treatment of variceal rehaemorrhage, whereas no patients undergoing HGPCS rebled. Within 30 days of shunting, occlusion requiring intervention or revision occurred in eight patients (20%) after TIPS. For three of these eight patients more than one intervention or revision was necessary. After HGPCS shunt thrombosis was documented on routine postoperative venography in three patients (8%). After TIPS seven patients underwent 11 late revisions due to occlusion or thrombosis. No late HGPCS revisions were necessary. After TIPS 12 patients were readmitted 20 times to have their shunts studied; after HGPCS 9 patients were readmitted for shunt evaluation. Early mortality was similar after each shunt. In total, 12 (30%) patients died after TIPS and nine (23%) died after HGPCS. After TIPS three patients were readmitted three times to treat encephalopathy andafter HGPCS seven patients were readmitted 12 times for treatment of encephalopathy. Five TIPS patients required seven readmissions for ascites. One HGPCS patient required one readmission to treat ascites. Cellulitis and abdominal pain necessitated readmission in four patients, two each after TIPS and HGPCS. Two additional readmissions after TIPS were necessitated by a perforated gastric ulcer complicated by intractable ascites and an infected peritoneovenous shunt.
Clinical conclusions
TIPS results in significantly higher readmission rates compared to HGPCS.
Measure of benefits used in the economic analysis
No summary benefit measure was identified in the economic analysis and only separate outcomes were reported.
Direct costs
The cost of care for patients undergoing shunting was determined beginning with placement of the shunt at the index admission. Costs incurred through subsequent admissions and care necessitated by ascites, encephalopathy, rebleeding due to portal hypertension, underlying cirrhosis, routine shunt monitoring, and revisions, when applicable, were recorded. In determining cost of care, hospital and clinic charges were used, as were physician charges. Hospital admissions unrelated to shunt complications or complications unrelated to the underlying cirrhosis or shunting were excluded from the cost analysis. Professional fees included all physician charges during the index hospitalisation beginning with shunt placement and including surgical fees, fees for ICU care, radiologists' fees and anesthesiologists' fees. It is not clear whether costs were discounted.
